Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.366NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.366NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-18000.3China
B.1.1.380NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.380NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.380NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.148NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.148NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.148NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.382NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.382NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.382NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.356NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.356NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.356NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.376NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.376NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.376NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.607NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.607NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.607NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.163NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.163NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.163NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.337NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.337NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.337NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.158NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.158NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.158NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.602NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.602NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.602NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.289NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.289NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.289NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DV.7.1.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DV.7.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.7.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDHNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDHNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDHNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.15.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.15.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.15.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.2.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.32NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.32NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used